Pathstone Holdings
ZBH icon

Pathstone Holdings’s Zimmer Biomet ZBH Stock Holding History

Pathstone Holdings’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Sell
36,890
-7,749
-17% -$679K 0.01% 864
2026
Q1 		$4.04M Buy
44,639
+587
+1% +$53.9K 0.02% 670
2025
Q4 		$3.96M Sell
44,052
-1,787
-4% -$169K 0.02% 664
2025
Q3 		$4.52M Buy
45,839
+7,333
+19% +$727K 0.02% 599
2025
Q2 		$3.51M Sell
38,506
-15,377
-29% -$1.49M 0.01% 692
2025
Q1 		$6.09M Sell
53,883
-15,271
-22% -$1.63M 0.03% 487
2024
Q4 		$7.3M Sell
69,154
-3,885
-5% -$417K 0.03% 419
2024
Q3 		$7.88M Buy
73,039
+3,612
+5% +$394K 0.03% 404
2024
Q2 		$7.54M Sell
69,427
-1,032
-1% -$122K 0.03% 396
2024
Q1 		$9.3M Buy
70,459
+40,126
+132% +$5.01M 0.04% 317
2023
Q4 		$3.7M Buy
+30,333
New +$3.38M 0.02% 519

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pathstone Holdings's ZBH Position: Q2 2026 in Review

Pathstone Holdings reduced its Zimmer Biomet (ZBH) stake by 17% in Q2 2026, selling an estimated $679K and leaving 36,890 shares worth $3.18M. The position accounts for 0.01% of the portfolio, ranked #864.

Pathstone Holdings first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.3M in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Pathstone Holdings held 36,890 shares of Zimmer Biomet worth $3.18M as of Q2 2026.
  • Pathstone Holdings sold 7,749 Zimmer Biomet shares in Q2 2026, an estimated $679K.
  • Zimmer Biomet made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #864 holding.
  • Pathstone Holdings first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Zimmer Biomet position peaked at $9.3M in Q1 2024.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.